Consolidation treatment with Yttrium-90 ibritumomab tiuxetan after new induction regimen in patients with intermediate- and high-risk follicular lymphoma according to the follicular lymphoma international prognostic index: A multicenter, prospective phase II trial of the Spanish Lymphoma Oncology Group
- Provencio, M.
- Cruz Mora, M.A.
- Gómez-Codina, J.
- Quero Blanco, C.
- Llanos, M.
- García-Arroyo, F.R.
- De La Cruz, L.
- Gumá Padró, J.
- Delgado Pérez, J.R.
- Sánchez, A.
- Álvarez Cabellos, R.
- Rueda, A.
ISSN: 1042-8194, 1029-2403
Argitalpen urtea: 2014
Alea: 55
Zenbakia: 1
Orrialdeak: 51-55
Mota: Artikulua